Innospec Ownership
| IOSP Stock | USD 83.02 1.99 2.34% |
Shares in Circulation | First Issued 1998-03-31 | Previous Quarter 24.9 M | Current Value 25.1 M | Avarage Shares Outstanding 25 M | Quarterly Volatility 1.2 M |
Innospec Stock Ownership Analysis
About 99.0% of the company shares are owned by institutional investors. The company has price-to-book (P/B) ratio of 1.64. Some equities with similar Price to Book (P/B) outperform the market in the long run. Innospec last dividend was issued on the 20th of May 2025. The entity had 2:1 split on the 23rd of July 2007. Innospec Inc. develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. Innospec Inc. was founded in 1938 and is headquartered in Englewood, Colorado. Innospec operates under Specialty Chemicals classification in the United States and is traded on NASDAQ Exchange. It employs 1900 people. To learn more about Innospec call Patrick Williams at 303 792 5554 or check out https://innospec.com.Besides selling stocks to institutional investors, Innospec also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Innospec's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Innospec's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Innospec Quarterly Liabilities And Stockholders Equity |
|
Innospec Insider Trades History
Only 1.25% of Innospec are currently held by insiders. Unlike Innospec's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Innospec's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Innospec's insider trades
Innospec Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Innospec is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Innospec backward and forwards among themselves. Innospec's institutional investor refers to the entity that pools money to purchase Innospec's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Hhg Plc | 2025-03-31 | 474.5 K | Nuveen Asset Management, Llc | 2024-12-31 | 471.1 K | Nuveen, Llc | 2025-03-31 | 453.5 K | Financial Harvest, Llc | 2025-03-31 | 433.8 K | Westwood Holdings Group Inc | 2025-03-31 | 382.4 K | Charles Schwab Investment Management Inc | 2025-03-31 | 354.7 K | Brown Advisory Holdings Inc | 2025-03-31 | 329.4 K | Northern Trust Corp | 2025-03-31 | 318.3 K | Jpmorgan Chase & Co | 2025-03-31 | 273 K | Blackrock Inc | 2025-03-31 | 3.7 M | Vanguard Group Inc | 2025-03-31 | 3.2 M |
Innospec Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Innospec insiders, such as employees or executives, is commonly permitted as long as it does not rely on Innospec's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Innospec insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Innospec Outstanding Bonds
Innospec issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Innospec uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Innospec bonds can be classified according to their maturity, which is the date when Innospec has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Innospec Corporate Filings
| 30th of May 2025 Other Reports | ViewVerify | |
F4 | 15th of May 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 14th of May 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 13th of May 2025 Other Reports | ViewVerify |
Pair Trading with Innospec
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Innospec position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Innospec will appreciate offsetting losses from the drop in the long position's value.Moving against Innospec Stock
The ability to find closely correlated positions to Innospec could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Innospec when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Innospec - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Innospec to buy it.
The correlation of Innospec is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Innospec moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Innospec moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Innospec can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Innospec Stock Analysis
When running Innospec's price analysis, check to measure Innospec's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Innospec is operating at the current time. Most of Innospec's value examination focuses on studying past and present price action to predict the probability of Innospec's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Innospec's price. Additionally, you may evaluate how the addition of Innospec to your portfolios can decrease your overall portfolio volatility.